APA (7th ed.) Citation

SL, R., A, S., PC, P., K, S., N, J., WH, F., . . . CB, C. (2025). Population Pharmacokinetic Modeling of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients With Cystic Fibrosis. The Journal of infectious diseases, 231(2), e364. https://doi.org/10.1093/infdis/jiae451

Chicago Style (17th ed.) Citation

SL, Rolsma, et al. "Population Pharmacokinetic Modeling of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients With Cystic Fibrosis." The Journal of Infectious Diseases 231, no. 2 (2025): e364. https://doi.org/10.1093/infdis/jiae451.

MLA (9th ed.) Citation

SL, Rolsma, et al. "Population Pharmacokinetic Modeling of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients With Cystic Fibrosis." The Journal of Infectious Diseases, vol. 231, no. 2, 2025, p. e364, https://doi.org/10.1093/infdis/jiae451.